|
|
||
|
Clinical
Randomisation of an Antifibrinolytic in Significant Haemorrhage
|
||
|
A
large randomised placebo controlled trial among trauma patients with,
or at risk of, significant haemorrhage, of the effects of antifibrinolytic
treatment on death and transfusion requirement
ISRCTN86750102 |
||
| INTRANET FOR COLLABORATORS | ||
| To receive the trial results when they are published in 2010, you can register your interest here. | ||
|
Peer reviewed Protocol is available on The Lancet protocol website »»» CLICK HERE |
||
|
20,000 PATIENTS RANDOMISED Congratulations to all our 274 collaborating hospitals in 40 countries for completing the randomisation of 20,000 patients! Results will be available in the near future. |
||
|
Last updated 11 February 2010
|
||